Pelish Henry E. (CIK 2029477) reported 67 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-15). Recent activity: Sell NUVL (22,393 shares), Sell NUVL (41,100 shares), Buy NUVL (14,350 shares), Sell NUVL (14,350 shares), Sell NUVL (2,111 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-15 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 22,393 | $2.8M |
| 2026-07-15 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 41,100 | $0 |
| 2026-07-15 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Buy | 14,350 | $0 |
| 2026-07-15 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 14,350 | $0 |
| 2026-07-10 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 2,111 | $261,363 |
| 2026-04-13 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Buy | 3,093 | $86,140 |
| 2026-04-13 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 2,193 | $228,664 |
| 2026-04-13 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 900 | $94,500 |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 24,189 | $2.4M |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Buy | 1,754 | $48,849 |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Buy | 4,125 | $120,986 |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Buy | 2,985 | $215,965 |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Buy | 8,456 | $160,072 |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 5,505 | $541,912 |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 306 | $30,331 |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 804 | $78,704 |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 2,597 | $256,662 |
| 2026-03-16 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 1,703 | $169,806 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 513 | $49,279 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 660 | $63,921 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 1,137 | $111,381 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 186 | $18,325 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 1,106 | $107,006 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 1,369 | $133,245 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Scientific Officer | Sell | 189 | $18,598 |
Source: SEC Form 4 filings · as of 2026-07-15